Zum Hauptinhalt springen

A pilot randomized controlled study to determine the effectiveness of video educational tool in BRCA1/2 pre-test counseling for Japanese breast cancer patients.

Nakamura, H ; Morinaga, S ; et al.
In: Journal of genetic counseling, 2024-06-09
Online academicJournal

Titel:
A pilot randomized controlled study to determine the effectiveness of video educational tool in BRCA1/2 pre-test counseling for Japanese breast cancer patients.
Autor/in / Beteiligte Person: Nakamura, H ; Morinaga, S ; Tsuchiya, K ; Sakoda, Y ; Ogino, M ; Ueno, S ; Tanino, H ; Kunihisa, T
Link:
Zeitschrift: Journal of genetic counseling, 2024-06-09
Veröffentlichung: Ahead of Print, 2024
Medientyp: academicJournal
ISSN: 1573-3599 (electronic)
DOI: 10.1002/jgc4.1928
Sonstiges:
  • Nachgewiesen in: MEDLINE
  • Sprachen: English
  • Publication Type: Journal Article
  • Language: English
  • [J Genet Couns] 2024 Jun 09. <i>Date of Electronic Publication: </i>2024 Jun 09.
  • References: Christian, S., Tagoe, J., Delday, L., Bernier, F. P., Kohut, R., & Ferrier, R. (2022). IMPACT webinars: Improving patient access to genetic counselling and testing using webinars—The Alberta experience with hypertrophic cardiomyopathy. Journal of Community Genetics, 13(1), 81–89. https://doi.org/10.1007/s12687‐021‐00564‐x. ; Christie, J., Quinn, G. P., Malo, T., Lee, J. H., Zhao, X., McIntyre, J., Brzosowicz, J., Jacobsen, P. B., & Vadaparampil, S. T. (2012). Cognitive and psychological impact of BRCA genetic counseling in before and after definitive surgery breast cancer patients. Annals of Surgical Oncology, 19(13), 4003–4011. https://doi.org/10.1245/s10434‐012‐2460‐x. ; Conley, C. C., Castro‐Figueroa, E. M., Moreno, L., Dutil, J., García, J. D., Burgos, C., Ricker, C., Kim, J., Graves, K. D., Ashing, K. T., Quinn, G. P., Soliman, H., & Vadaparampil, S. T. (2021). A pilot randomized trial of an educational intervention to increase genetic counseling and genetic testing among Latina breast cancer survivors. Journal of Genetic Counseling, 30(2), 394–405. https://doi.org/10.1002/jgc4.1324. ; Cragun, D., Weidner, A., Tezak, A., Zuniga, B., Wiesner, G. L., & Pal, T. (2020). A web‐based tool to automate portions of pretest genetic counseling for inherited cancer. Journal of the National Comprehensive Cancer Network, 18(7), 841–847. https://doi.org/10.6004/jnccn.2020.7546. ; Domchek, S. M., Friebel, T. M., Singer, C. F., Evans, D. G., Lynch, H. T., Isaacs, C., Garber, J. E., Neuhausen, S. L., Matloff, E., Eeles, R., Pichert, G., Van t'veer, L., Tung, N., Weitzel, J. N., Couch, F. J., Rubinstein, W. S., Ganz, P. A., Daly, M. B., Olopade, O. I., … Rebbeck, T. R. (2010). Association of risk‐reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA, 304(9), 967–975. https://doi.org/10.1001/jama.2010.1237. ; Gradishar, W. J., Moran, M. S., Abraham, J., Aft, R., Agnese, D., Allison, K. H., Anderson, B., Burstein, H. J., Chew, H., Dang, C., Elias, A. D., Giordano, S. H., Goetz, M. P., Goldstein, L. J., Hurvitz, S. A., Isakoff, S. J., Jankowitz, R. C., Javid, S. H., Krishnamurthy, J., … Kumar, R. (2022). Breast cancer, version 3.2022, NCCN clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network, 20(6), 691–722. https://doi.org/10.6004/jnccn.2022.0030. ; Heemskerk‐Gerritsen, B. A., Rookus, M. A., Aalfs, C. M., Ausems, M. G., Collee, J. M., Jansen, L., Kets, C. M., Keymeulen, K. B., Koppert, L. B., Meijers‐Heijboer, H. E., Mooij, T. M., Tollenaar, R. A., Vasen, H. F., HEBON, Hooning, M. J., & Seynaeve, C. (2015). Improved overall survival after contralateral risk‐reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: A prospective analysis. International Journal of Cancer, 136(3), 668–677. https://doi.org/10.1002/ijc.29032. ; Hurtado‐de‐Mendoza, A., Graves, K. D., Gómez‐Trillos, S., Carrera, P., Campos, C., Anderson, L., Luta, G., Peshkin, B. N., Schwartz, M. D., Cupertino, A. P., Gonzalez, N., & Sheppard, V. B. (2019). Culturally targeted video improves psychosocial outcomes in Latina women at risk of hereditary breast and ovarian cancer. International Journal of Environmental Research and Public Health, 16(23), 4793. https://doi.org/10.3390/ijerph16234793. ; Japan Organization of Hereditary Breast and Ovarian Cancer (JOHBOC). (2020). To help you understand Hereditary Breast and Ovarian Cancer Syndrome (HBOC) ver.2020_1 [Japanese]. [Data file] https://johboc.jp/wp/wp‐content/uploads/2021/05/hboc_ver2020_01.pdf. ; Joseph, G., Beattie, M. S., Lee, R., Braithwaite, D., Wilcox, C., Metrikin, M., Lamvik, K., & Luce, J. (2010). Pre‐counseling education for low literacy women at risk of hereditary breast and ovarian cancer (HBOC): Patient experiences using the cancer risk education intervention tool (CREdIT). Journal of Genetic Counseling, 19(5), 447–462. https://doi.org/10.1007/s10897‐010‐9303‐3. ; Julious, S. A. (2005). Sample size of 12 per group rule of thumb for a pilot study. Pharmaceutical Statistics, 4, 287–291. https://doi.org/10.1002/pst.185. ; Kanda, Y. (2013). Investigation of the freely available easy‐to‐use software ‘EZR’ for medical statistics. Bone Marrow Transplantation, 48(3), 452–458. https://doi.org/10.1038/bmt.2012.244. ; Kawaguchi, T., Azuma, K., Yamaguchi, T., Soeda, H., Sekine, Y., Koinuma, M., Takeuchi, H., Akashi, T., & Unezaki, S. (2013). Development and validation of the Japanese version of the decisional conflict scale to investigate the value of pharmacists' information: A before and after study. BMC Medical Informatics and Decision Making, 13(1), 50. https://doi.org/10.1186/1472‐6947‐13‐50. ; Kuchenbaecker, K. B., Hopper, J. L., Barnes, D. R., Phillips, K. A., Mooij, T. M., Roos‐Blom, M. J., Jervis, S., van Leeuwen, F. E., Milne, R. L., Andrieu, N., Goldgar, D. E., Terry, M. B., Rookus, M. A., Easton, D. F., Antoniou, A. C., BRCA1 and BRCA2 Cohort Consortium, McGuffog, L., Evans, D. G., Barrowdale, D., … Olsson, H. (2017). Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA, 317(23), 2402–2416. https://doi.org/10.1001/jama.2017.7112. ; Mavaddat, N., Peock, S., Frost, D., Ellis, S., Platte, R., Fineberg, E., Evans, D. G., Izatt, L., Eeles, R. A., Adlard, J., Davidson, R., Eccles, D., Cole, T., Cook, J., Brewer, C., Tischkowitz, M., Douglas, F., Hodgson, S., Walker, L., … EMBRACE. (2013). Cancer risks for BRCA1 and BRCA2 mutation carriers: Results from prospective analysis of EMBRACE. Journal of the National Cancer Institute, 105(11), 812–822. https://doi.org/10.1093/jnci/djt095. ; Nakagomi, H., Sakamoto, I., Hirotsu, Y., Amemiya, K., Mochizuki, H., Inoue, M., Nakagomi, S., Kubota, T., & Omata, M. (2016). Willingness of Japanese patients with breast cancer to have genetic testing of BRCA without burden of expenses. Breast Cancer, 23(4), 649–653. https://doi.org/10.1007/s12282‐015‐0618‐7. ; Nilsson, M. P., Nilsson, E. D., Borg, Å., Brandberg, Y., Silfverberg, B., & Loman, N. (2019). High patient satisfaction with a simplified BRCA1/2 testing procedure: Long‐term results of a prospective study. Breast Cancer Research and Treatment, 173(2), 313–318. https://doi.org/10.1007/s10549‐018‐5000‐y. ; O'Conner, A. M. (1993). User manual – Decisional conflict scale. https://decisionaid.ohri.ca/docs/develop/User_Manuals/UM_Decisional_Conflict.pdf. ; O'Conner, A. M. (1995). Validation of a decisional conflict scale. Medical Decision Making, 15, 25–30. https://doi.org/10.1177/0272989X9501500105. ; Rebbeck, T. R., Kauff, N. D., & Domchek, S. M. (2009). Meta‐analysis of risk reduction estimates associated with risk‐reducing salpingo‐oophorectomy in BRCA1 or BRCA2 mutation carriers. Journal of the National Cancer Institute, 101(2), 80–87. https://doi.org/10.1093/jnci/djn442. ; Robson, M. E., Bradbury, A. R., Arun, B., Domchek, S. M., Ford, J. M., Hampel, H. L., Lipkin, S. M., Syngal, S., Wollins, D. S., & Lindor, N. M. (2015). American Society of Clinical Oncology policy Statement update: Genetic and genomic testing for cancer susceptibility. Journal of Clinical Oncology, 33(31), 3660–3667. https://doi.org/10.1200/JCO.2015.63.0996. ; Sim, J., & Lewis, M. (2012). The size of a pilot study for a clinical trial should be calculated in relation to considerations of precision and efficiency. Journal of Clinical Epidemiology, 65(3), 301–308. https://doi.org/10.1016/j.jclinepi.2011.07.011. ; Slingsby, B. T. (2004). Decision‐making models in Japanese psychiatry: Transitions from passive to active patterns. Social Science & Medicine, 59(1), 83–91. https://doi.org/10.1016/j.socscimed.2003.10.006. ; Specker Sullivan, L. (2017). Dynamic axes of informed consent in Japan. Social Science & Medicine, 174, 159–168. https://doi.org/10.1016/j.socscimed.2016.12.031. ; Tutt, A. N. J., Garber, J. E., Kaufman, B., Viale, G., Fumagalli, D., Rastogi, P., Gelber, R. D., de Azambuja, E., Fielding, A., Balmaña, J., Domchek, S. M., Gelmon, K. A., Hollingsworth, S. J., Korde, L. A., Linderholm, B., Bandos, H., Senkus, E., Suga, J. M., Shao, Z., … OlympiA Clinical Trial Steering Committee and Investigators. (2021). Adjuvant Olaparib for patients with BRCA1‐ or BRCA2‐mutated breast cancer. The New England Journal of Medicine, 384(25), 2394–2405. https://doi.org/10.1056/NEJMoa2105215. ; Wang, C., Gonzalez, R., Million, K. J., Strecher, V. J., & Merajver, S. D. (2005). Genetic counseling for BRCA1/2: A randomized controlled trial of two strategies to facilitate the education and counseling process. American Journal of Medical Genetics. Part A, 134A(1), 66–73. https://doi.org/10.1002/ajmg.a.30577.
  • Contributed Indexing: Keywords: BRCA1/2; decision‐making; genetic counseling; genetic testing; hereditary breast and ovarian cancer; video educational tool
  • Entry Date(s): Date Created: 20240609 Latest Revision: 20240609
  • Update Code: 20240610

Klicken Sie ein Format an und speichern Sie dann die Daten oder geben Sie eine Empfänger-Adresse ein und lassen Sie sich per Email zusenden.

oder
oder

Wählen Sie das für Sie passende Zitationsformat und kopieren Sie es dann in die Zwischenablage, lassen es sich per Mail zusenden oder speichern es als PDF-Datei.

oder
oder

Bitte prüfen Sie, ob die Zitation formal korrekt ist, bevor Sie sie in einer Arbeit verwenden. Benutzen Sie gegebenenfalls den "Exportieren"-Dialog, wenn Sie ein Literaturverwaltungsprogramm verwenden und die Zitat-Angaben selbst formatieren wollen.

xs 0 - 576
sm 576 - 768
md 768 - 992
lg 992 - 1200
xl 1200 - 1366
xxl 1366 -